Related Experiment Video

Updated: Jun 18, 2026

Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs
12:44

Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs

Published on: January 27, 2023

Efficient inhibition of the formation of joint adhesions by ERK2 small interfering RNAs

Fengfeng Li1, Hongjiang Ruan, Cunyi Fan

  • 1Department of Orthopaedics, The Sixth Affiliated People's Hospital, Shanghai Jiaotong University School of Medicine, 600 Yishan Road, Shanghai 200233, China.

Biochemical and Biophysical Research Communications
|December 5, 2009
PubMed

Insights

Targeting extracellular signal-regulated kinase 2 (ERK2) with siRNA effectively reduces joint adhesions. This safe and effective method softens adhesions and decreases contracture angles, offering a promising therapeutic approach.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Transforming growth factor-beta1 and fibroblast growth factor-2 are key regulators of fibroblast proliferation and collagen expression.
  • These processes contribute to joint adhesion formation via SMAD and MAPK pathways.
  • Extracellular signal-regulated kinase 2 (ERK2) is a critical component in these signaling pathways.

Purpose of the Study:

  • To investigate the efficacy of lentivirus-mediated small interfering RNA (siRNA) targeting ERK2 in suppressing joint adhesion formation in vivo.
  • To assess the safety and effectiveness of ERK2 siRNA delivery for mitigating joint adhesions.

Main Methods:

  • Lentivirus-mediated siRNA targeting ERK2 was administered locally in an in vivo model.
  • Joint adhesion formation was evaluated using adhesion scoring, histological analysis, and measurement of joint contracture angles.

Main Results:

  • The ERK2 siRNA group exhibited softened and weakened adhesions that were easily stretched.
  • A significant reduction in flexion contracture angles was observed in the ERK2 siRNA group compared to the control (P<0.05).
  • No adverse effects, such as impaired wound healing, were noted in the treated animals.

Conclusions:

  • Local delivery of lentivirus-mediated siRNA targeting ERK2 effectively ameliorates joint adhesion formation.
  • This therapeutic strategy is both effective and safe for managing joint adhesions.

Related Concept Videos

RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...